Investors are Betting Against Ironwood Pharmaceuticals, Inc. (IRWD), Should You? - Tale of the Tape

By
A A A

Many investors appear to be quite bearish on Ironwood Pharmaceuticals, Inc. ( IRWD ) , especially if you look at the percentage of the float that is sold short for this stock. Currently, 27.91% of the float is sold short, suggesting an extreme level of bearishness for IRWD .

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2(Buy) on IRWD, so we clearly don't believe in the negativity surrounding this firm, and are instead looking for shares of IRWD to move higher in the weeks ahead.



IRONWOOD PHARMA (IRWD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: IRWD

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com